Exploring the mechanism of cardiorenal protection with finerenone based on network pharmacology

Large prospective trials have demonstrated that finerenone could reduce the risk of cardiovascular death and progression of renal failure among patients with chronic kidney disease (CKD) associated heart failure (HF) and/or type 2 diabetes mellitus (T2DM). The aim of this study was to explore the mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiorenal medicine 2024-01, Vol.14 (1), p.334
Hauptverfasser: Si, Yachen, Zhu, Ying, Liu, Jing, Liu, Shuyu, Cai, Xiaomin, Gu, Ying, Li, Hanqing, Pan, Fang, Wang, Wenjuan, Shangguan, Jianying, Liu, Rui, Xi, Chunsheng, Wang, Lijun
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!